SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494) (HBIO) — Dec 16, 2015

HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494)
Date: Dec. 16, 2015 · CIK: 0001123494 · Accession: 0000000000-15-058177

Regulatory Compliance Financial Reporting Internal Controls

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
December 31, 2014
Author
/s/ Geoff Kruczek for
Form
UPLOAD
Company
HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494)

Letter

Mail Stop 3030 December 16 , 2015 Via E -mail Jeffrey A. Duchemin Chief Executive Officer Harvard Bioscience, Inc. 84 October Hill Road Holliston, Massachusetts 01746

Re: Harvard Bioscience, Inc. Form 10-K for the fiscal year ended December 31, 2014 Filed March 12, 2015 File No. 001 -33957

Dear Mr. Duchemin :

We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities la ws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Geoff Kruczek for

Show Raw Text
Mail Stop 3030

December 16 , 2015

Via E -mail
Jeffrey A. Duchemin
Chief Executive Officer
Harvard Bioscience, Inc.
84 October Hill Road
Holliston, Massachusetts 01746

Re: Harvard Bioscience, Inc.
 Form 10-K for the fiscal year ended December 31, 2014
Filed March 12, 2015
File No. 001 -33957

Dear Mr. Duchemin :

We have completed our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities la ws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Geoff Kruczek  for

 Amanda Ravitz
Assistant Director
Office of Electronics and Machinery

cc (via e-mail):  Chad J. Burns , Esq.
 Burns & Levinson LLC